1 Johnston SC，Amarenco P. Ticagrelor versus Aspirin in

Acute Stroke or Transient Ischemic Attack[J]. N Engl J

Med，2016，375：35-43.

2 Qureshi AI，Palesch YY，Barsan WG，et al. ATACH-2

Trial Investigators and the Neurological Emergency

Treatment Trials Network. Intensive Blood-Pressure

Lowering in Patients with Acute Cerebral Hemorrhage[J].

N Engl J Med，2016;375：1033-1043.

3 Anderson CS，Robinson T，Lindley RI，et al.

ENCHANTED Investigators and Coordinators. Low-Dose

versus Standard-Dose Intravenous Alteplase in Acute

Ischemic Stroke[J]. N Engl J Med，2016，374：2313-2323.

4 Wang Y，Wang Y，Zhao X，Let al. Clopidogrel with

aspirin in acute minor stroke or transient ischemic

attack[J]. N Engl J Med，2013，369：11-19.

5 Wong KS，Wang Y，Leng X. Early dual versus mono

antiplatelet therapy for acute non-cardioembolic ischemic

stroke or transient ischemic attack：an updated systematic

review and meta-analysis[J]. Circulation，2013，128：

1656-1666.

6 Wang YL，Pan YS，Zhao XQ，et al. Recurrent Stroke

was Associated with Poor Quality of Life in Patients with

Transient Ischemic Attack or Minor Stroke：Finding from

the CHANCE Trial[J]. CNS Neurosci Ther，2014，20：

1029-1035.

7 Wang X，Zhao X，Johnston SC，et al. Effect of

clopidogrel with aspirin on functional outcome in TIA or

minor stroke：CHANCE substudy[J]. Neurology，2015，

85：573-579.

8 Liu L，Wong KS，Leng X，et al. Dual antiplatelet therapy

in stroke and ICAS：Subgroup analysis of CHANCE[J].

Neurology，2015，85：1154-1162.

9 Pan YS，Meng X，Jing J，et al. Association of multiple

infarctions and ICAS with outcomes of minor stroke and

TIA[J]. Neurology，2017，88：1081-1088.

10 Li JJ，Zhao X，Meng X，et al. High-Sensitive C-Reactive

Protein Predicts Recurrent Stroke and Poor Functional

Outcome：Subanalysis of the Clopidogrel in High-Risk

Patients With Acute Nondisabling Cerebrovascular Events

Trial[J]. Stroke，2016，47：2025-2030.

11 Li J，Wang Y，Lin J，et al. Soluble CD40L Is a Useful

Marker to Predict Future Strokes in Patients With

Minor Stroke and Transient Ischemic Attack[J]. Stroke，

2015，46：1990-1992.

12 Lin J，Zheng H，Cucchiara BL，et al. Association of

Lp-PLA2-A and early recurrence of vascular events

after TIA and minor stroke[J]. Neurology，2015，85：

1585-1591.

13 Pan Y，Jing J，Li H，et al. Abnormal glucose

regulation increases stroke risk in minor ischemic

stroke or TIA[J]. Neurology，2016，87：1551-1556.

14 Li J，Wang Y，Wang D，et al. Glycated albumin

predicts the effect of dual and single antiplatelet

therapy on recurrent stroke[J]. Neurology，2015，84：

1330-1336.

15 Zhou Y，Pan Y，Wu Y，et al. Effect of Estimated

Glomerular Filtration Rate Decline on the Efficacy

and Safety of Clopidogrel With Aspirin in Minor

Stroke or Transient Ischemic Attack：CHANCE

Substudy (Clopidogrel in High-Risk Patients With

Acute Nondisabling Cerebrovascular Events)[J].

Stroke，2016，47：2791-2796.

16 Wang Y，Zhao X，Lin J，et al. Association Between

CYP2C19 Loss-of-Function Allele Status and Efficacy

of Clopidogrel for Risk Reduction Among Patients

With Minor Stroke or Transient Ischemic Attack[J].

JAMA，2016，316：70-78.

17 Pan Y，Chen W，Xu Y，et al. Genetic Polymorphisms

and Clopidogrel Efficacy for Acute Ischemic Stroke or

Transient Ischemic Attack：A Systematic Review and

Meta-Analysis[J]. Circulation，2017，135：21-33.

18 Lin Y，Wang A，Li J，et al. Impact of Glycemic Control

on Efficacy of Clopidogrel in Transient Ischemic Attack

or Minor Stroke Patients With CYP2C19 Genetic

Variants[J]. Stroke，2017，48：998-1004.

19 Ovbiagele B，Wang J，Johnston SC，et al. Effect of

Clopidogrel by Smoking Status on Secondary Stroke

Prevention[J]. Circulation，2017，135：315-316.

20 Wang Y，Pan Y，Zhao X，et al. Clopidogrel With

Aspirin in Acute Minor Stroke or Transient Ischemic

Attack (CHANCE) Trial：One-Year Outcomes[J].

Circulation，2015，132：40-46.

21 Li Z，Wang Y，Zhao X，et al. Treatment Effect of

Clopidogrel Plus Aspirin Within 12 Hours of Acute

Minor Stroke or Transient Ischemic Attack[J]. J Am

Heart Assoc，2016，5：e003038.

22 Pan Y，Jing J，Chen W，et al. Risks and benefits of

clopidogrel-aspirin in minor stroke or TIA：Time

course analysis of CHANCE[J]. Neurology，2017，doi：

10.1212/WNL.0000000000003941.